Anaesthetic agents Flashcards

1
Q

A patient requires ongoing muscle relaxation during a lengthy operation. His past medical includes renal and liver impairment form alcohol. Which of the non depolarising blocking drugs can be used?

A Pancuronium
B Rocuronium
C Atracurium
D Vecuronium

A

C

Explanation
Atracurium is cleared form circulation via Hofamnn elimination-nonenzymatic and enzymatic hydrolysis of ester bonds. It is not dependent of organ function. Fever and alkalosis does increase metabolism of atracurium (Hofmann elimination increases)

Mivacurium metabolized via plasma cholinesterase and would be useful to use as well

Pancuronium, rocuronium and vecuronium rely on liver and/or kidney metabolism to clear the drug

Extra:

Atracurium kinetics and dynamics are near-normal even in patients with fulminant hepatic failure and renal failure; laudanosine accumulation will occur, but this is not associated with measurable central neurological effects. Implantation of a functioning liver graft results in clearance of laudanosine, which seems to be independent of renal function. Atracurium is an appropriate choice for producing neuromuscular blockade for periods of several days in patients with fulminant hepatic failure and renal impairment.

Intensive Care Med 1993;19 Suppl 2:S94-8.Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation. Bion JF et al

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which volatile anaesthetic is the least metabolized?

A Sevoflurane
B Desflurane
C Isoflurane
D Halothane

A

B

Explanation
The extent of hepatic metabolism, the order (most to least) of inhaled anaesthetic are methoxyflurane, halothane, enflurane, sevoflurane, isoflurane, desflurane, nitrous oxide. Nitrous oxide undergoes zero metabolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which of the following is an amide local anaesthetic agent?

A Benzocaine
B Prilocaine
C Cocaine
D Tetracaine

A

B

Explanation
All the rest are Ester type local anaesthetics. Examples of Amide local anaesthetics are: lignociane, mepivacaine, bupivacaine, etidocaine and ropivacaine

Note- a nice way to remember it: local anaesthetics that are Esters :have just one ‘’ i ‘’ in their names eg procaine ,cocaine but Amides :have more than one ‘’ i ‘’ in their names lidocaine, bupivacaine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In pseudo (plasma) cholinesterase deficiency which of these two drugs will have a prolonged effect?

A Remifentanil and Esmolol
B Succinylcholine and Esmolol
C Mivacurium and Esmolol
D Succinylcholine and Procaine

A

D

Explanation
Pseudocholinesterase deficiency will result in a prolonged effect of the following: succinylcholine, mivacurium, procaine, and cocaine.

Iatrogenic causes of lower plasma pseudocholinesterase activity include medications such as the following:

Anticholinesterase inhibitors
Bambuterol
Chlorpromazine
Contraceptives
Cyclophosphamide
Echothiophate eye drops
Esmolol (esmolol is metabolised by esterases in the cytosol of red cells, not plasma or red cell membrane acetylcholinesterases)
Glucocorticoids
Hexafluorenium
Metoclopramide
Monoamine oxidase inhibitors
Pancuronium
Phenelzine
Tetrahydroaminacrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prolonged duration of neuromuscular blockade is seen following a vecuronium infusion. Which of the following is NOT a possible cause?

A Acidosis
B Long term steroid use
C Severe burns
D Hypothermia

A

B

Explanation
In rare cases, long-term use of neuromuscular blocking drugs to fascilitate mechanical ventilation in ICU settings may be associated with prolonged paralysis and/or skeletal muscle weakness. Patients may have received other drugs such as broad spectrum antibiotics, narcotics and steroids and may have severe diseases which lead to electrolyte imbalances, hypoxic episodes of varying duration, acid-base imbalance, hyperthermia and extreme debilitation any of which may enhance the actions of a neuromuscular blocking agent.

Hypothermia increases the duration of action and increases the time to recovery. Reduced clearance and rate of effect site equilibration may explain vecuronium’s increased duration of action when core temperature is reduced.

Severe burns and those with upper motor neuron disease are resistant to nondepolarising muscle relaxants. This desensitization is probably caused by proliferation of extrajunctional receptors, which result in an increased dose requirement for the nondepolarising relaxant to block a sufficient number of receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which of these drugs can be used to treat central anticholinergic syndrome?

A Physostigmine
B Atropine
C Pyridostigmine
D Benztropine

A

A

Explanation
Physositgmine is the only carbamate that is well absorbed form all sites (lungs, skin, eye, gut) and is distributed into the central nervous system.

EXTRA

Many of the drugs used in anesthesia and intensive care may cause blockade of the central cholinergic neurotransmission. Acetylcholine is of significance in modulation of the interaction among most other central transmitters. The clinical picture of the central cholinergic blockade, known as the central anticholinergic syndrome (CAS), is identical with the central symptoms of atropine intoxication. This behaviour consists of agitation including seizures, restlessness, hallucinations, disorientation or signs of depression such as stupor, coma and respiratory depression. Such disturbances may be induced by opiates, benzodiazepines, phenothiazines, butyrophenones, ketamine, etomidate, propofol, nitrous oxide, and halogenated inhalation anesthetics as well as by H2-blocking agents such as cimetidine. There is an individual predisposition for CAS–but unpredictable from laboratory findings or other signs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which of the following opioids have only INACTIVE metabolites?

A Oxycodone
B Codeine
C Methadone
D Morphine

A

C

Explanation
Morphine=hydromorphone.

Codeine= morphine

Oxycodone= oxymorphone.

Pethidine = norpethidine

Unlike codeine, morphine, hydromorphone, pethidine or oxycodone-methadone has no active metabolites and is therefore a good choice for patients at risk for toxicity from metabolite accumulation

Extra:

Morphine is primarily conjugated to morphine-3-glucuronide (M3G), a compound with neuroexcitatory properties. 10% of morphine is metabolised to morphine-6-glucuronide (M6G), an active metabolite with analgesic potency of four to six times that of its parent compound. These relative polar metabolites have limited ability to cross the BBB and probably do not contribute significantly to the usual CNS effects of a single dose of morphine. More importantly, accumulation of these metabolites may produce unexpected adverse effects in patients with renal failure or when exceptionally large doses of morphine are administered or high doses are administered over long periods. This can result in M3G-induced CNS excitation (seizures) or enhanced and prolonged opioid action produced by M6G.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

With the MAOI tranylcypromine, which drug will be least problematic?

A Propofol
B Phenylephrine
C Ephedrine
D Pethidine

A

A

Explanation
Tranylcypromine is a MAOI, which will inhibit the catabolism of dietary amines-prevents breakdown of tyramine in the gut. When foods containing tyramine (cheese, tap beer, soy products and dried sausage) are ingested, the patient may develop a hypertensive crisis. The mechanism is poorly understood but is thought that tyramine displaces noradrenaline from the storage vesicles and enhance peripheral noradrenergic effects, including raising blood pressure dramatically. Similarly drugs with sympathommimetic properties may cause significant hypertension when combined with MAOIs. Over-the-counter preparations that contain pseudoephedrine and phenylpropanolamine are contraindicated in patients taking MAOIs. Pethidine is associated with serotonin syndrome when given with the MAOI drug group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which drug does NOT have antiemetic properties?

A Ketamine
B Dexamethasone
C Midazolam
D Ondansetron

A

A

Explanation
Ketamine does not have antiemetic properties but is often used with propofol=Ketofol, as Propofol has antiemetic effects. The antiemetic effect of Propofol is stated in the current texts, but there is some controversy as to whether it really works as an antiemetic. See different articles reports below.

In a study reported in the clinical journal of anaesthetics it stated that many anaesthesiologists used propofol for its antiemetic effect. There is strong evidence for its antiemetic efficacy after anaesthesia maintained by a propofol infusion and also for its use in the post anaesthetic patient. However, there is little evidence to support its use purely at induction of anaesthesia or using it at the beginning or end of a case in an attempt to reduce postoperative nausea and vomiting. This is especially true in cases lasting longer than a few minutes

Other studies have reported: The group anaesthetised with propofol had significantly fewer emetic sequelae and the results suggest that propofol has a definite antiemetic action.

Online reports: Propofol is known to possess direct antiemetic effects. Propofol antiemetic use for induction and maintenance of anaesthesia has been shown to be associated with a lower incidence of postoperative nausea and vomiting (PONV) when compared to any other anaesthetic drug or technique.

Extra: The antiemetic effect of midazolam or/and ondansetron added to intravenous patient controlled analgesia in patients of pelviscopic surgery: 2012: Dae Seong Kimetal etal. Conclusion: Midazolam added to PCA using fentanyl proved more effective than ondansetron in preventing PONV without adverse effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which of the following inhaled gases are metabolised greater than 10%?

A Isoflurane
B Nitrous oxide
C Halothane
D Sevoflurane

A

C

Explanation
Metabolism of inhaled anaesthetics:

Halothane >40%

Enflurane 8%

Sevoflurane 2-5%

Isoflurane <2%

Nitrous oxide 0%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which of the following is most likely to cause raised intracranial pressure?

A Diazepam
B Ketamine
C Propofol
D Thiopentone

A

B

Explanation
Ketamine markedly increases cerebral blood flow, cerebral oxygen consumption and intracranial pressure. Inhaled anaesthetics decrease the metabolic rate of the brain but do increase cerebral blood flow. Thiopentone decreases cerebral metabolism, oxygen consumption and cerebral blood flow. Propofol reduces cerebral blood flow and cerebral metabolism. Benzodiazepines decrease cerebral blood flow and ICP but to a smaller extent

Note: I have seen nitrous oxide as an option. Nitrous does increase cerebral blood flow and ICP

Extra: the latest review of ketamine in the prescribed TB states that ketamine is considered to be a vasodilator that increases cerebral blood flow as well as CMR02. Traditionally ketamine has not been used in patient with an already raised ICP. New evidence suggests that this undesired effect on cerebral blood flow may be blunted by the maintenance of normocapnia

Life in the fast lane literature review, states that there is no evidence that ketamine causes harm in traumatic brain injury and that Ketamine haemodynamic stability may actually be of benefit in TBI requiring rapid sequence induction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The following cause an increase in intra-abdominal pressure?

A Metoclopramide
B Neostigmine
C Suxamethonium
D Morphine

A

C

Explanation
In some patients especially muscular ones, the fasiculations associated with suxamethonium will cause a rise in intra gastric pressure from 5-40cmH20. The result of which may cause vomiting and aspiration. This effect is not seen with the non depolarising muscle relaxants

Succinylcholine is a depolarizing neuromuscular blocker, meaning it causes a prolonged period of membrane depolarization in order to exert its therapeutic effects. It binds to the post-synaptic cholinergic receptors found on motor endplates, thereby inducing first transient fasciculations followed by skeletal muscle paralysis

Neostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. The drug inhibits acetylcholinesterase which is responsible for the degredation of acetylcholine. So, with acetylcholinesterase inhibited, more acetylcholine is present. By interfering with the breakdown of acetylcholine, neostigmine indirectly stimulates both nicotinic and muscarinic receptors which are involved in muscle contraction.. It does not cross the blood-brain barrier. Neostigmine is a cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier. By inhibiting acetylcholinesterase, more acetylcholine is available in the synapse, therefore, more of it can bind to the fewer receptors present in myasthenia gravis and can better trigger muscular contraction.

Metoclopramide causes antiemetic effects by inhibiting dopamine D2 and serotonin 5-HT3 receptors in the chemoreceptor trigger zone (CTZ) located in the area postrema of the brain. Administration of this drug leads to prokinetic effects via inhibitory actions on presynaptic and postsynaptic D2 receptors, agonism of serotonin 5-HT4 receptors, and antagonism of muscarinic receptor inhibition. This action enhances the release of acetylcholine, causing increased lower esophageal sphincter (LES) and gastric tone, accelerating gastric emptying and transit through the gut. Metoclopramide antagonizes the dopamine D2 receptors. Dopamine exerts relaxant effect on the gastrointestinal tract through binding to muscular D2 receptor. Because of its antidopaminergic activity, metoclopramide can cause symptoms of tardive dyskinesia (TD), dystonia, and akathisia, and should therefore not be administered for longer than 12 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which of the following increase intra-ocular pressure?

A Hypoventilation
B Halothane
C Suxamethonium
D Ketamine

A

C

Explanation
Intraocular pressure increases following administration of suxamethonium. It occurs 1 min after injection, is maximal at 2-4 min and starts to subside after 5min. The mechanism may involve contractions of tonic myofibrils or transient dilation of chorodial blood vessels. Despite this increase, the use of suxamethonium is not contraindicated unless the anterior chamber is to be opened.

Note: in the current textbook, there is no mention of Ketamine’s effect on IOP. A web review states that ketamine does cause a small rise in IOP but not enough to be a concern. At dosages of 4 mg/kg or less, there are not clinically meaningful associations of ketamine with elevation of IOP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Thiopentone is a “short-lasting” barbiturate because?

A It is administrated by IV injection
B It is metabolised rapidly by brain and liver
C It is rapidly distributed throughout the body
D It is bound to the “sleep centre” in the brain

A

C

Explanation
It is “short lasting” because of the rapid removal form brain tissue into the other highly vascularised tissues and is redistributed to muscle, fat and eventually all body tissues. It is only metabolised at a rate of 12-16% following a single dose. It facilitates the action of GABA and increase the opening of the Cl channels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which of the following may be administered via the tracheal mucosa?

A Calcium chloride
B Theophylline
C Lignocaine
D Suxamethonium

A

C

Explanation
Resuscitation drugs such as Naloxone, Atropine, Vasopressin, Epinephrine, Lignocaine.
(Mnemonic for resuscitation drugs that may be given down the ET tube is NAVEL) are absorbed via the trachea. Administration of resuscitation drugs into the trachea, however, results in lower blood concentrations than the same dose given intravascularly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Your emergency department wants to buy Sugammadex. You present a CME on the important pharmacodynaics and pharmacokinetic of the drug. Which of the following is true?

A It is effective in reversing both selective and non selective
B 4mg/kg is the dose required for immediate reversal of neuromuscular blocker
C Muscle recovery with Sugammadex is faster than neostigmine
D It is safe to use in patients with renal failure

A

C

Explanation
Sugammadex is a modified gamma cyclodextrin designed to selectively reverse the effects of the neuromuscular blockers rocuronium and vecuronium. There is evidence to suggest it is effective against pancuronium. It works by forming a complex with these drugs, reducing their availability to bind to nicotinic receptors in the neuromuscular junction

IVI administration, sugammadex has an elimination half-life of 2.2 hours. This is increased in elderly patients and decreased in children. M of the sugammadex dose is excreted unchanged in the urine, so its use in people with severe renal impairment is not recommended. Longer recovery times may be observed in older patients as well as people with cardiovascular disease, oedema or severe hepatic impairment.

If immediate reversal of rocuronium-induced blockade is required, the recommended dose is 16mg/kg of sugammadex three minutes after rocuronium administration. Currently there is no evidence to recommend sugammadex for the complete reversal of vecuronium.

4mg/kg is required for reversal of a deep block (post tetanic count 1 to 2). 2mg/kg is required for a shallow block (train of four =2). Sugammadex is more effective than neostigmine at reversing profound and shallow neuromuscular blockade

T1/2 is 2.2 hours. Following reversal of block there has been reports of recurrence of blockade. Close drug monitoring is required

17
Q

Which of the following local anaesthetics shortens the action potential duration?

A Lignocaine
B Bupivacaine
C Ropivacaine
D Prilocaine

A

A

Explanation
Class 1b antiarrhytmic drugs shorten the action potential. Lignocaine is a 1b antiarrhythmic drug. Other drugs include mexiletine. Class 1a lengthens the action potential and class 1c does not affect the action potential. Lignociane is the drug of choice for the termination of ventricular tachycardia and prevention of ventricular fibrillation after cardioversion in the ischaemic setting.

From the textbook:

Drugs with class 1B action shortens the APD (action potential duration) in some tissues of the heart and dissociate from the channel with rapid kinetics

18
Q

The side effects of suxamethonium involve all of the following except:

A Tachycardia
B Muscle fasciculations
C Urinary retention
D Excess salivation

A

C

Explanation
Suxamethonium is a rapid onset muscle relaxant which has a short duration. It is contraindicated with a family history of malignant hyperthermia, severe liver disease and hyperkalemia. Side effects include muscle pain, fasciculation and myoglobinaemia, tachycardia or bradycardia (both eMIMS and a websearch say both), hypertension and hypotension, bronchospasm, hyperkalaemia and hyperthermia. It may also cause excess salivation but not urinary retention.

Direct from the TB

Succinylcholine can cause cardiac arrhythmias, especially when administered during halothane anesthesia. The drug stimulates autonomic cholinoceptors, including the nicotinic receptors at both sympathetic and parasympathetic ganglia and muscarinic receptors in the heart (eg, sinus node). The negative inotropic and chronotropic responses to Succinylcholine can be attenuated by administration of an anticholinergic drug (eg, glycopyrrolate, atropine). With large doses of Succinylcholine, positive inotropic and chronotropic effects may be observed. On the other hand, bradycardia has been repeatedly observed when a second dose of Succinylcholineis given less than 5 minutes after the initial dose. This transient bradycardia can be prevented by thiopental, atropine, and ganglionic-blocking drugs, and by pretreating with a small dose of a nondepolarizing muscle relaxant (eg,rocuronium). Direct myocardial effects, increased muscarinic stimulation, and ganglionic stimulation contribute to this bradycardic response.

It acts by mimicking acetylcholine at the neuromuscular junction. It cannot be reversed but is short acting.

Katzung: Basic and clinical pahrmacology 15th

Note:

The question could be worded better- but I have chosen to leave it as is!

The adverse effects of suxamethonium include all of the following EXCEPT? (Rather than SIDE effects)

An extension of the pharmacological effects of suxamethoium include all the following EXCEPT?

19
Q

A patient who is now day 4 stay in ICU with airway burns, requires intubation. Which of the following muscle relaxant drugs is CONTRAINDICATED?

A Gallamine
B Succinylcholine
C Vecuronium
D Rocuronium

A

B

Explanation
Hyperkalaemia from tissue destruction may complicate management during acute resuscitation. Despite the risk of hyperkalaemia due to the burn, succinylcholine is ONLY contraindicated after the first 24hrs of the burn.

Normal muscle releases enough potassium during succinylcholine-induced depolarisation to raise the serum K by 0.5mmol/L. While this is insignificant in patients with normal serum potassium levels, a life threatening potassium elevation in patients with burn injuries, massive trauma, neurological disorders, severe sepsis, spinal cord injury, tetanus, closed head injury and denervation injuries is possible. Subsequent cardiac arrest may occur which can be quite refractive to conventional resuscitation requiring HCO3, insulin/glucose, dantrolene, (cation-exchange resin), calcium, bypass to reduce metabolic acidosis and hyperkalaemia. In denervation injuries, ACH receptor develops outside the neuromuscular junction (up-regulation). These extra-junctional receptors allow succinylcholine to effect wide spread depolarisation and excessive potassium release. Life threatening is not reliably prevented by a non depolariser type drug either. The risk of hyperkalaemia usually appears to peak in 7-10 days following injury, but the exact time of onset and the duration of the risk period vary

Note: cation exchange resins are usually not effective after a single dose and may produce serious side effects, especially in patients who are postoperative, patients with ileus or bowel obstruction or have transplanted organs. Bowel necrosis may occur. Due to these severe side effects, resins should only be used in patients who have life threatening hyperkalaemia, dialysis not readily available and other therapies to remove potassium have failed or are not possible

EXTRA:

Patients with severe burns and those with upper motor neuron disease are resistant to non-depolarising muscle relaxants. This desensitization is probably caused by proliferation of extra-junctional receptors, which results in an increased dose requirement for the non-depolarising relaxant to block a sufficient number of receptors

Patients with burns, nerve damage or neuromuscular disease, closed head injury, and other trauma may develop proliferation of extra junctional acetylcholine receptors. During administration of succinylcholine, potassium is released from muscles, likely due to fasciculations. If the proliferation of extra junctional receptors is great enough, sufficient potassium may be released to result in cardiac arrest. The exact time course of receptor proliferation s unknown, it is best to avoid the use of succinylcholine in these cases

20
Q

Which of the following inhaled anaesthetics DOES NOT trigger malignant hyperthermia?

A Ether
B Sevoflurane
C Nitrous oxide
D Halothane

A

C

Explanation
Malignant hyperthermia (MH) can be triggered by halogenated general anaesthetics including: ether, cyclopropane, halothane, methoxyflurane, enflurane, isoflurane, desflurane, sevoflurane. Nitrous gas does not trigger MH. Succinylcholine can also trigger MH

Advantages of N2O
- Inert, non toxic
- Minimal CVS effects
- Low blood solubility
- Rapid induction and recovery
- Environmentally friendly
- Non-explosive

Disadvantages
- MAC (>100%)
- High cost
- No commercially available anaesthetic equipment

21
Q

Which anaesthetic drug is best described in the following scenerios..

This short acting muscle relaxant is eliminated by hydrolysing cholinesterases

A Rocuronium
B Sugammadex
C Atracurium
D Succinylcholine

A

D

Explanation
This question appears an EMQ

Succinylcholine short duration of action is due to rapid hydrolysis by butyrylcholinesterase and pseudocholinesterase in the liver and plasma respectively

Extra EMQ type questions

A patient requires a rapidly acting non-depolarising muscle relaxant that is primarily metabolised by the liver= rocuronium

An anaesthetised patient has been given rocuronium, at the end of his procedure , reversal is managed with this modified cyclodextran=sugammedex

This muscle relaxant is appropriate in a patient with severe renal and hepatic impairment= atracurium

Atracurium is so extensively metabolised that its pharmacokinetic are independent of renal and hepatic function, and less than 10% is excreted unchanged by renal or biliary routes. Two separate processes are responsible for metabolism: ester hydrolysis and Hofmann elimination

22
Q

90yr old female undergoes a laparotomy for peritonitis. She is slow to regain muscle strength post-operative. Which drug is responsible?

A Ampicillin
B Vancomycin
C Gentamicin
D Metronidazole

A

C

Explanation
Gentamicin increases the effect of the neuromuscular blocking agents (including suxamethonium)

The aminoglycosides (neomycin, gentamicin, tobramycin) and the lincosamides (clindamycin) potentiate neuromuscular blockade, although generally, not at clinically significant doses.

23
Q

A patient fractures his wrist. He receives a Bier’s block to reduce the fracture. Soon after drug administration he becomes cyanosed and his blood has a chocolate colour. Which local anaesthetic drug is responsible?

A Lignociane
B Bupivacaine
C Prilocaine
D Ropivacaine

A

C

Explanation
Prilocaine had the highest clearance of the amino-amide anaesthetics, imparting reduced risk of systemic toxicity. Unfortunately, this is somewhat offset by its propensity to induce methaemaglobinaemia

Healthy patients who have normal haemoglobin concentrations do not usually develop clinical effects until the methemoglobin level rises above 20% of the total haemoglobin.At methaemoglobin levels between 20% and 30%, anxiety, headache, weakness, and light-headedness develop, and patients may exhibit tachypnea and sinus tachycardia. Methaemoglobin levels of 50% to 60% impair oxygen delivery to vital tissues, resulting in myocardial ischemia, dysrhythmias, depressed mental status (including coma), seizures, and lactate-associated metabolic acidosis. Levels above 70% are largely incompatible with life.

Cyanosis associated with methaemoglobin is often described as a gray discoloration of skin, with a detection threshold for methemoglobin of 1.5 grams/dL, corresponding to methaemoglobin levels between 10% and 15% in a non-anemic individual. Methaemoglobin levels above 20% will discolour the blood a chocolate brown.

Source: Tintinalli’s Emergency medicine

24
Q

A 40-year-old man with chronic renal failure is intubated. Which neuromuscular blocking agent is most appropriate to maintain sedation?

A Pancuronium
B Atracurium
C Rocuronium
D Vecuronium

A

B

Explanation
Atracurium is an intermediate-acting non-depolarising muscle relaxant, which undergoes hepatic metabolism and Hoffman elimination (spontaneous breakdown). The other agents have a component of renal elimination.

25
Q

A patient with ESRF (end stage renal failure) presents with constipation. You are worried about fluid shifts and electrolyte disturbances. Which is the best muscle relaxant to use to keep him paralysed?

A Atracurium
B Pancuronium
C Vecuronium
D Rocuronium

A

A

Explanation
Atracurium is an intermediate-acting isoquinoline nondepolarizing muscle relaxant that is no longer in widespread clinical use (replaced by cisactracurium) . In addition to hepatic metabolism, atracurium is inactivated by a form of spontaneous breakdown known as Hofmann elimination. Pancuronium undergoes 80% renal elimination. Rocuronium and Vecuronium both undergo hepatic (75 – 90%) and renal elimination

26
Q

Which neuromuscular blocker is primarily metabolised in the plasma

A Succinylcholine
B Vecuronium
C Rocuronium
D Atracurium

A

A

Explanation
Nondepolarizing: The rate of disappearance of nondepolarizing neuromuscular blocking drugs from the blood involves a rapid initial distribution phase followed by a slower elimination phase. Their metabolism differs based on the specific drug:

Steroid derivatives (Pancuronium, Rocuronium, Vecuronium): Primarily metabolized in the liver (75-90% for rocuronium and vecuronium), with a smaller portion excreted by the kidneys. The liver metabolizes them into 3-hydroxy, 17-hydroxy, or 3,17-dihydroxy products. These metabolites are less potent than the parent drugs but can accumulate with prolonged use.

Isoquinoline derivatives (Atracurium, Cisatracurium): Atracurium is metabolized both hepatically and by spontaneous Hofmann elimination (breakdown into laudanosine and a quaternary acid). Cisatracurium, a less potent isomer, is largely metabolized spontaneously. The spontaneous breakdown process is less dependent on hepatic function.

Tubocurarine: Approximately 40% is excreted by the kidneys, with the remainder via other routes.

Depolarizing (Succinylcholine): Primarily metabolized by plasma cholinesterase (butyrylcholinesterase and pseudocholinesterase). The primary metabolite, succinylmonocholine, is further broken down into succinic acid and choline. The rate of metabolism is influenced by genetic variants of plasma cholinesterase. Succinylcholine’s extremely short duration of action (5-10 minutes) is due to its rapid hydrolysis by butyrylcholinesterase and pseudocholinesterase in the liver and plasma, with plasma cholinesterase metabolism being the predominant pathway.

The nondepolarizing steroid muscle relaxants (Vecuronium and Rocuronium) are more dependent on hepatic metabolism for elimination than the long-acting steroid-based drugs. It also highlights that the duration of action of these agents may be prolonged significantly in patients with impaired liver function.

Source: Katzung pharmacolgy 15ed

27
Q

Sugammadex has NO affinity for which non-depolarising neuromuscular blocker

A Atracurium
B Pancuronium
C Vecuronium
D Rocuronium

A

A

Explanation
Although the eight identical hydroxyl side chains of sugammadex were specifically designed to bind rocuronium, the other steroidal muscle relaxants, vecuronium and pancuronium, are also bound by sugammadex, albeit with a much lower affinity

Steroid derivatives (Pancuronium, Rocuronium, Vecuronium): Primarily metabolized in the liver (75-90% for rocuronium and vecuronium), with a smaller portion excreted by the kidneys. The liver metabolizes them into 3-hydroxy, 17-hydroxy, or 3,17-dihydroxy products. These metabolites are less potent than the parent drugs but can accumulate with prolonged use.

Isoquinoline derivatives (Atracurium, Cisatracurium): Atracurium is metabolized both hepatically and by spontaneous Hofmann elimination (breakdown into laudanosine and a quaternary acid). Cisatracurium, a less potent isomer, is largely metabolized spontaneously. The spontaneous breakdown process is less dependent on hepatic function.